SUFENTA Drug Patent Profile
✉ Email this page to a colleague
When do Sufenta patents expire, and when can generic versions of Sufenta launch?
Sufenta is a drug marketed by Rising, Hikma, Hospira, and Watson Labs. and is included in four NDAs.
The generic ingredient in SUFENTA is sufentanil citrate. There are nine drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the sufentanil citrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Sufenta
A generic version of SUFENTA was approved as sufentanil citrate by HOSPIRA on December 11th, 1996.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for SUFENTA?
- What are the global sales for SUFENTA?
- What is Average Wholesale Price for SUFENTA?
Summary for SUFENTA
| US Patents: | 0 |
| Applicants: | 4 |
| NDAs: | 4 |
| Drug Prices: | Drug price information for SUFENTA |
| DailyMed Link: | SUFENTA at DailyMed |
US Patents and Regulatory Information for SUFENTA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rising | SUFENTA PRESERVATIVE FREE | sufentanil citrate | INJECTABLE;INJECTION | 019050-001 | May 4, 1984 | AP | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Watson Labs | SUFENTANIL CITRATE | sufentanil citrate | INJECTABLE;INJECTION | 074406-001 | Dec 15, 1995 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hikma | SUFENTANIL CITRATE | sufentanil citrate | INJECTABLE;INJECTION | 074413-001 | Dec 15, 1995 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hospira | SUFENTANIL CITRATE | sufentanil citrate | INJECTABLE;INJECTION | 074534-001 | Dec 11, 1996 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
